Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Case Studies in Optimal Management of Anti-FXa-DOAC-Associated Intracranial Hemorrhage: Specific vs Nonspecific Anticoagulant Reversal

Program Overview

This CME program is derived from content presented at the 8th European Stroke Organization Conference (ESOC 2022). This educational activity, chaired by Dr. Thorsten Steiner, will review optimal management strategies of patients with anti-FXa-DOAC-associate Intracranial Hemorrhage (ICH). The worldwide utilization of DOACs for a number of different indications has continuously increased over the past decade, and while the ...
View Course
Evidence Based Dietary and Pharmacologic Approaches to Manage Patients with Hyperkalemia and Associated Comorbidities – Modules 3 & 4

Program Overview

This CME program will highlight evidence based dietary and pharmacologic approaches to manage patients with hyperkalemia. In module 3, Dr. George Bakris will analyze the clinical trial data for newer therapeutic options to treat patients with hyperkalemia. Following, Dr. Matthew Weir will lead a faculty discussion to further delve into these trials and how they relate to patient ...
View Course

Evidence Based Dietary and Pharmacologic Approaches to Manage Patients with Hyperkalemia and Associated Comorbidities – Modules 1 & 2

Program Overview

This CME program will highlight evidence based dietary and pharmacologic approaches to manage patients with hyperkalemia. Starting with module 1, Dr. Biff Palmer will review the science of recurrent hyperkalemia, including relationships between dietary potassium intake, serum potassium, and patient morbidities. Next, in module 2, Dr. Pamela Kushner will evaluate the limitations and impact of plant-based diets and ...
View Course

The Role of Neonatal Fc Receptor (FcRn) Blocking Therapeutics in the Management of Patients with Generalized Myasthenia Gravis

Program Overview

This CME program will highlight recent advances in the treatment and management of patients with myasthenia gravis (MG). The expert faculty, Dr. James F. Howard Jr., will first outline the pathophysiology and disease course of MG, referencing the impact of treatment and disease burden on patients. Following, current clinical trial data, including that of complement inhibitor therapies in ...
View Course
Update on Best Practices for the Prompt and Personalized Management of Patients with COPD Exacerbations

Program Overview

This CME program is derived from content presented at the 2022 Eastern Pulmonary Conference. The expert faculty, Dr. William Corrao, will first highlight strategies for early diagnosis and classification of chronic obstructive pulmonary disease (COPD), referencing the current Gold Guidelines. Following, current clinical trial data will be reviewed, and clinical relevance debated in an interactive panel format. Dr ...
View Course
Advances in the Diagnosis and Management of Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE): The Role of Dipeptidyl Peptidase 1 (DPP1) Inhibitor Therapeutics

Program Overview

This CME program is derived from content presented at the 2022 Eastern Pulmonary Conference. The expert faculty, Dr. Gregory Tino, will first outline the pathophysiology, prevalence and radiological distribution of non-cystic fibrosis bronchiectasis (NCFBE). Current treatment guidelines and recommendations for patients with NCFBE will be reviewed and an overview of phenotyping provided. Dr. Tino will conclude with an ...
View Course

Upcoming Events

ASHP Midyear Clinical Meeting and Exhibition

December 6th, 2022

ESMO Immuno-Oncology Congress 2022

December 7th – 9th, 2022

Florida Society of Neurology Annual Meeting

January 6th – 7th, 2023

Advanced Curriculum for Multiple Sclerosis 2023

February 21st – 22nd, 2023